Infinata’s BioPharm Insight Releases its Catalyst Monitor for March…

Key catalysts include US approval decisions for Zogenix, Biogen Idec, and Johnson & Johnson.

(PRWeb February 26, 2013)

Read the full story at

Comments are closed.

Get email updates

Get new actionable insights and updates from BiotechBlog

Do NOT follow this link or you will be banned from the site!